《Journal of Huazhong University of Science and Technology (Medical Sciences)》《華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué))(英德文版)》(雙月刊)創(chuàng)刊于1978年,郵發(fā)代碼:38-56,由華中科技大學(xué)主辦以英文(或德文)刊登醫(yī)學(xué)及其相關(guān)領(lǐng)域科研論文的學(xué)術(shù)期刊。 《Journal of Huazhong University of Science and Technology (Medical Sciences)》主要刊登基礎(chǔ)醫(yī)學(xué)、預(yù)防醫(yī)學(xué)、法醫(yī)學(xué)、藥學(xué)、中醫(yī)中藥學(xué)等方面的科研論文及臨床研究,介紹先進(jìn)的診療技術(shù)。讀者對(duì)象為國(guó)內(nèi)外高級(jí)醫(yī)藥、衛(wèi)生、科技人員。 《Journal of Huazhong University of Science and Technology (Medical Sciences)》是我國(guó)最早進(jìn)入美國(guó)醫(yī)學(xué)文摘(IM)檢索系統(tǒng)的刊物之一,之后進(jìn)入全球最大數(shù)據(jù)庫PubMed供世界各國(guó)研究工作者查詢,2005年被世界著名出版公司Springer公司“中國(guó)在線圖書館”全文收錄,2007年被美國(guó)《科學(xué)引文索引》(SCI-E)收錄。同時(shí),本刊多次榮獲國(guó)家有關(guān)部門和省政府的表彰與獎(jiǎng)勵(lì)。
是我國(guó)最早進(jìn)入美國(guó)醫(yī)學(xué)文摘(IM)檢索系統(tǒng)的刊物之一,之后進(jìn)入全球最大數(shù)據(jù)庫PubMed供世界各國(guó)研究工作者查詢,2005年被世界著名出版公司Springer公司“中國(guó)在線圖書館”全文收錄,2007年被美國(guó)《科學(xué)引文索引》(SCI-E)收錄
讀者對(duì)象為國(guó)內(nèi)外高級(jí)醫(yī)藥、衛(wèi)生、科技人員
CA 化學(xué)文摘(美);SCI 科學(xué)引文索引(美);萬方收錄(中);上海圖書館館藏;劍橋科學(xué)文摘;國(guó)家圖書館館藏;文摘與引文數(shù)據(jù)庫;知網(wǎng)收錄(中);維普收錄(中)
本刊多次榮獲國(guó)家有關(guān)部門和省政府的表彰與獎(jiǎng)勵(lì)
2018年 第1期目錄
(1)Preventive and Therapeutic Potential of Vitamin C in Mental Disorders
韓倩倩[1];諶甜甜[1];王芳[1];吳鵬飛[1,2,3,4];陳建國(guó)[1,2,3,4]
(11)Kinsenoside:A Promising Bioactive Compound from Anoectochilus Species
齊昌興[1];周群[1];周淵[1];羅增偉[1];代沖[1];朱虎成[1];陳春梅[1];薛永波[1];汪建平[1];王亞芬[1];劉亞平[1];向明[1];孫偉光[1];張錦文[2];張勇慧[1]
(19)Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression:A Hypothesis
劉暢[1];羅彬[2,3];謝小薰[2,3];廖興勝[1];付駿[2];葛盈盈[2,3];李希圣[1];郭高水[1];沈?qū)嶽4];肖紹文[1];張慶梅[2,3]
(26)Hepatitis B Virus X Protein Upregulates Intracellular Calcium Signaling by Binding C-terminal of Orai1 Protein
姚景宏[1];劉子建[2];易建華[1];王君[3];劉亞男[1]
(35)Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3
郭豪[1];林生彥[2];任文翔[1];雷倩[1,2];陳智超[1];張璐[1];李秋柏[1]
(43)Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients:a Meta-analysis
牟時(shí)代[1];艾利莎[2];秦鈾[2];胡豫[1]
(51)Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
周繼豪;林海清;沈琦;胡麗娜;李國(guó)強(qiáng);孫雄飛;張新友
(58)Down-regulation of Helios Expression in Tregs from Patients with Hypertension
陳朱越[1];陳鳳[2];王燕鴿[1];王定航[1];蔣麗麗[1];程龍獻(xiàn)[1]
(64)Relationship between Physical Inactivity and Long-term Outcome in Patients Aged ≥80 Years with Acute Coronary Syndrome
李世軍[1,2];Salim Barywani[2];Michael FU[2]
(70)Bioinformatics Analysis of Genes and Pathways of CD11b^+/Ly6C^intermediate Macrophages after Renal Ischemia-Reperfusion Injury
孫冬[1];萬辛[1];潘斌斌[1];孫晴[2];嵇小兵[1];張峰[1];張浩[1];曹長(zhǎng)春[1,2]
(78)Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer:a Single Institution Investigation in China
朱光勝[1];田少博[1];王輝[1];麻懋光[1];劉亞[1,2];杜寒松[1];龍躍平[1]
(85)New Nano-Film Single-Rivet Patent Ductus Arteriosus Occluders:A Prospective,Randomized and Double-blind Study
尚小珂[1,2];柳梅[3];李紅軍[4];盧蓉[3];丁珊珊[5];王斌[1];董念國(guó)[1];陳澍[1]
(93)Rapamycin Treatment Attenuates Angiotensin Ⅱ-induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity
李飛飛;尚小珂;杜心靈;陳澍
(101)Efficacy and Safety of Treatment of High-flow Priapism with Superselective Transcatheter Embolization
齊濤[1];葉雷[1];陳征[2];黃展森[1];王博[1];李浩[1];張濱[1,3];陳俊[1]
(107)Low-temperature Plasma Promotes Fibroblast Proliferation in Wound Healing by ROS-activated NF-κB Signaling Pathway
石興民[1];許桂敏[2];張冠軍[2];劉進(jìn)仁[1];吳月明[1];高菱鴿[1];楊陽[1];常正實(shí)[2];姚聰偉[2]
(115)PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK,p-p38 and the p-ERK/MAPK Signaling Pathway
鄭紅云[1,2];申復(fù)進(jìn)[3];童永清[1,2];李艷[1,2]
(124)Conditioned Medium from Human Umbilical Vein Endothelial Cells Promotes Proliferation,Migration,Invasion and Angiogenesis of Adipose Derived Stem Cells
駱名戀[1,2];劉小平[1];王芳[1];劉曉夏[1];劉維芳[1];吳迪[1];陶惠[1];王絨莉[1];趙茵[1];朱劍文[1];鄒麗[1]
(131)Role of ICSI in Non-male Factor Cycles as the Number of Oocytes Retrieved Decreases from Four to One
郭娜;華香;李豫峰;靳鐳
(137)Clinical Assessment of Differential Diagnostic Methods in Infants with Cholestasis due to Biliary Atresia or Non-Biliary Atresia
董琛[1];朱慧云[1];陳云超[2];羅小平[1];黃志華[1]
(144)Combination Therapy with LXW7 and Ceria Nanoparticles Protects against Acute Cerebral Ischemia/Reperfusion Injury in Rats
張婷[1];李常艷[2];賈靜靜[1];池潔珊[1];周達(dá)[3];李鑒洲[1];劉小馬[1];張軍[2];易黎[1]
(153)Fusarium solani Activates Dectin-1 in Experimentally Induced Keratomycosis
徐玲娟[1];謝立信[2]
(160)Effect of Srt A on Interspecies Adherence of Oral Bacteria
宋穎[1,2];何金枝[1,3];王人可[1,3];馬凈植[4];鄒玲[1,3]
(167)Pharmacokinetic Characteristics of Baicalin in Rats with 17α-ethynylestradiol-induced Intrahepatic Cholestasis
張程亮;徐艷嬌;向東;楊金玉;雷凱;劉東
(174)B Vitamins Can Reduce Body Weight Gain by Increasing Metabolism-related Enzyme Activities in Rats Fed on a High-Fat Diet
鄭櫻[1];馬愛國(guó)[2];鄭明慈[3];汪求真[2];梁惠[2];韓秀霞[1];Evert G.Schouten[4]
(184)Satisfaction about Patient-centeredness and Healthcare System among Patients with Chronic Multimorbidity
周朝華[1];唐尚鋒[1];王旭輝[2];陳茁[3];張冬蘭[3];高俊良[1];Bishwajit GHOSE[4];馮達(dá)[1];賀知菲[1];Sanni YAYA[4];馮占春[1]
(191)Effects of Testosterone Supplementation on Body Composition in HIV Patients:A Meta-analysis of Double-blinded Randomized Controlled Trials
周婷;扈智勇;章慧平;趙凱;臧煜;李穎;魏家靜;袁紅方
1.主要刊登基礎(chǔ)醫(yī)學(xué)、臨床醫(yī)學(xué)、預(yù)防醫(yī)學(xué)、環(huán)境醫(yī)學(xué)、法醫(yī)學(xué)、藥學(xué)和中醫(yī)中藥學(xué)等方面的論文。讀者對(duì)象為國(guó)內(nèi)外高級(jí)醫(yī)藥、衛(wèi)生、科技人員。歡迎廣大科技、醫(yī)務(wù)工作者踴躍投稿。
2.文稿應(yīng)具科學(xué)性、創(chuàng)新性、邏輯性,并有理論和實(shí)踐意義。論點(diǎn)鮮明,資料可靠,數(shù)據(jù)準(zhǔn)確,結(jié)論明確,文字簡(jiǎn)練,層次清楚,打印工整
3.來稿附上英文紙質(zhì)稿一份(和中文翻譯稿兩份),英文稿件電子版請(qǐng)發(fā)至電子郵箱xbyk@mails.tjmu.edu.cn。注明第一作者的性別,職稱及第一作者或聯(lián)系人的電話號(hào)碼,E-mail地址。
4.來稿須經(jīng)作者所在單位審核并附單位推薦信。推薦信應(yīng)證明內(nèi)容不涉及保密、署名無爭(zhēng)議、未一稿兩投等項(xiàng)。
5.論著采用敘述式摘要。關(guān)鍵詞一般3~5個(gè),請(qǐng)采用最新版的MeSH詞表(醫(yī)學(xué)主題詞注釋字順表)中的主題詞。MeSH詞表中無該詞時(shí),方可用習(xí)用的自由詞。使用縮略語時(shí),應(yīng)在文中首次出現(xiàn)處寫明英文全稱。
6.表格采用三線表,表序按正文中出現(xiàn)的順序連續(xù)編碼。數(shù)據(jù)不多、欄目過繁、文字過多者均不宜列表。表內(nèi)同一指標(biāo)數(shù)字的有效位數(shù)應(yīng)一致。
7.線條圖應(yīng)另紙描繪,全圖外廓以矩形為宜,高寬比例約為5∶7,避免過于扁寬或狹長(zhǎng)。照片圖須清晰,像素高,層次分明,圖題及圖解說明清楚。
8.參考文獻(xiàn)必須以作者親自閱讀過的近年文獻(xiàn)為主,并由作者對(duì)照原文核實(shí)(請(qǐng)作者在文章發(fā)表前提供PubMed等數(shù)據(jù)庫的所含文獻(xiàn)頁面)。文獻(xiàn)一般不少于30篇。內(nèi)部刊物、未發(fā)表資料、私人通訊等勿作參考文獻(xiàn)引用。參考文獻(xiàn)的編號(hào)按照在正文中出現(xiàn)的先后順序排列,用阿拉伯?dāng)?shù)字加方括號(hào)角注。并按引用的先后順序排列于文末。
9.投稿者請(qǐng)自留底稿。請(qǐng)勿一稿兩投。論文如以中文或其它文種在他刊發(fā)表,本刊將不再刊用。來稿一律文責(zé)自負(fù)。
請(qǐng)登錄后再使用評(píng)論功能
去登錄